| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 34.60B | 6.79B | 6.25B | 19.14B | 16.39B |
| Gross Profit | 20.24B | 6.79B | 6.25B | 6.56B | 6.89B |
| EBITDA | 7.13B | 20.52B | 18.58B | 14.76B | 8.58B |
| Net Income | 4.65B | 3.71B | 3.52B | 5.18B | 4.71B |
Balance Sheet | |||||
| Total Assets | 537.24B | 445.22B | 403.40B | 389.41B | 399.18B |
| Cash, Cash Equivalents and Short-Term Investments | 148.41B | 88.04B | 83.90B | 87.79B | 103.57B |
| Total Debt | 174.37B | 330.19B | 269.21B | 141.79B | 140.47B |
| Total Liabilities | 500.53B | 409.43B | 369.41B | 355.31B | 370.37B |
| Stockholders Equity | 35.91B | 35.36B | 33.48B | 33.16B | 28.56B |
Cash Flow | |||||
| Free Cash Flow | -8.91B | 5.27B | -6.05B | -12.20B | 9.57B |
| Operating Cash Flow | -8.34B | 6.33B | -4.09B | -11.38B | 10.55B |
| Investing Cash Flow | -48.14B | -2.34B | -3.88B | -1.23B | -31.13B |
| Financing Cash Flow | 66.17B | -1.94B | -2.99B | 450.00M | 72.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $38.78B | 36.22 | 19.89% | 0.46% | 12.92% | 28.20% | |
74 Outperform | $29.33B | 13.83 | 17.21% | 1.26% | 5.83% | 1.44% | |
73 Outperform | $344.27B | 18.31 | 16.38% | 2.14% | 16.32% | 29.43% | |
70 Outperform | $153.04B | 16.46 | 19.08% | 1.07% | 8.11% | 53.31% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | $60.98B | 18.52 | 13.72% | 3.06% | 6.35% | 33.56% | |
64 Neutral | $322.33B | 17.46 | 14.58% | 1.55% | 2.63% | 26.98% |